These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 35817569)

  • 21. Ketamine plus midazolam compared to midazolam infusion for the management of refractory status epilepticus.
    Fletman EW; Cleymaet S; Salvatore A; Devlin K; Pickard A; Shah SO
    Clin Neurol Neurosurg; 2024 Nov; 246():108592. PubMed ID: 39418930
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of cholinergic-induced status epilepticus with polytherapy targeting GABA and glutamate receptors.
    Niquet J; Nguyen D; de Araujo Furtado M; Lumley L
    Epilepsia Open; 2023 May; 8 Suppl 1(Suppl 1):S117-S140. PubMed ID: 36807554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Potential consequences of high-dose infusion of ketamine for refractory status epilepticus: case reports and systematic literature review.
    Golub D; Yanai A; Darzi K; Papadopoulos J; Kaufman B
    Anaesth Intensive Care; 2018 Sep; 46(5):516-528. PubMed ID: 30189827
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increasing Ketamine Use for Refractory Status Epilepticus in US Pediatric Hospitals.
    Keros S; Buraniqi E; Alex B; Antonetty A; Fialho H; Hafeez B; Jackson MC; Jawahar R; Kjelleren S; Stewart E; Morgan LA; Wainwright MS; Sogawa Y; Patel AD; Loddenkemper T; Grinspan ZM
    J Child Neurol; 2017 Jun; 32(7):638-646. PubMed ID: 28349774
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rational polytherapy in the treatment of cholinergic seizures.
    Niquet J; Lumley L; Baldwin R; Rossetti F; Suchomelova L; Naylor D; Estrada IBF; Schultz M; Furtado MA; Wasterlain CG
    Neurobiol Dis; 2020 Jan; 133():104537. PubMed ID: 31454548
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ketamine for the treatment of refractory status epilepticus.
    Fang Y; Wang X
    Seizure; 2015 Aug; 30():14-20. PubMed ID: 26216679
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous Ketamine Bolus(es) for the Treatment of Status Epilepticus, Refractory Status Epilepticus, and Cluster Seizures: A Retrospective Study of 15 Dogs.
    Roynard P; Bilderback A; Dewey CW
    Front Vet Sci; 2021; 8():547279. PubMed ID: 33681317
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intravenous ganaxolone for the treatment of refractory status epilepticus: Results from an open-label, dose-finding, phase 2 trial.
    Vaitkevicius H; Ramsay RE; Swisher CB; Husain AM; Aimetti A; Gasior M
    Epilepsia; 2022 Sep; 63(9):2381-2391. PubMed ID: 35748707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of Refractory Convulsive Status Epilepticus: A Comprehensive Review by the American Epilepsy Society Treatments Committee.
    Vossler DG; Bainbridge JL; Boggs JG; Novotny EJ; Loddenkemper T; Faught E; Amengual-Gual M; Fischer SN; Gloss DS; Olson DM; Towne AR; Naritoku D; Welty TE
    Epilepsy Curr; 2020 Sep; 20(5):245-264. PubMed ID: 32822230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factors associated with treatment delays in pediatric refractory convulsive status epilepticus.
    Sánchez Fernández I; Gaínza-Lein M; Abend NS; Anderson AE; Arya R; Brenton JN; Carpenter JL; Chapman KE; Clark J; Gaillard WD; Glauser TA; Goldstein JL; Goodkin HP; Helseth AR; Jackson MC; Kapur K; Lai YC; McDonough TL; Mikati MA; Nayak A; Peariso K; Riviello JJ; Tasker RC; Tchapyjnikov D; Topjian AA; Wainwright MS; Wilfong A; Williams K; Loddenkemper T;
    Neurology; 2018 May; 90(19):e1692-e1701. PubMed ID: 29643084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of ketamine for pediatric and adolescent super-refractory status epilepticus and the effect of cerebral inflammatory conditions.
    Kuki I; Inoue T; Fukuoka M; Nukui M; Okuno H; Amo K; Otsuka Y; Ishikawa J; Rinka H; Ujiro A; Togawa M; Shiomi M; Okazaki S
    J Neurol Sci; 2024 Apr; 459():122950. PubMed ID: 38461760
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terminating prolonged refractory status epilepticus using ketamine.
    Hsieh CY; Sung PS; Tsai JJ; Huang CW
    Clin Neuropharmacol; 2010 May; 33(3):165-7. PubMed ID: 20098301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of ketamine in a newborn with refractory status epilepticus: a case report.
    Tarocco A; Ballardini E; Garani G
    Pediatr Neurol; 2014 Jul; 51(1):154-6. PubMed ID: 24938144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Spectrum and Predictors of Refractory Status Epilepticus in a Developing Country.
    Dubey D; Bhoi SK; Kalita J; Misra UK
    Can J Neurol Sci; 2017 Sep; 44(5):538-546. PubMed ID: 28446263
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Continuous infusion, general anesthesia and other intensive care treatment for uncontrolled status epilepticus.
    Tasker RC; Vitali SH
    Curr Opin Pediatr; 2014 Dec; 26(6):682-9. PubMed ID: 25313975
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus.
    Arya R; Peariso K; Gaínza-Lein M; Harvey J; Bergin A; Brenton JN; Burrows BT; Glauser T; Goodkin HP; Lai YC; Mikati MA; Fernández IS; Tchapyjnikov D; Wilfong AA; Williams K; Loddenkemper T;
    Epilepsy Res; 2018 Aug; 144():1-6. PubMed ID: 29727818
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Refractory status epilepticus: a developing country perspective.
    Sinha S; Prashantha DK; Thennarasu K; Umamaheshwara Rao GS; Satishchandra P
    J Neurol Sci; 2010 Mar; 290(1-2):60-5. PubMed ID: 19954801
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single versus combinatorial therapies in status epilepticus: Novel data from preclinical models.
    Löscher W
    Epilepsy Behav; 2015 Aug; 49():20-5. PubMed ID: 25819944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A systematic review and meta-analysis of ketamine in pediatric status epilepticus.
    Chiriboga N; Spentzas T; Abu-Sawwa R
    Epilepsia; 2024 Aug; 65(8):2200-2212. PubMed ID: 38881333
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study.
    Fisch U; Jünger AL; Baumann SM; Semmlack S; De Marchis GM; Hunziker S; Rüegg S; Marsch S; Sutter R
    Neurology; 2023 May; 100(19):e1955-e1966. PubMed ID: 36889924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.